Circulating endothelial markers and ischemic status in peripheral occlusive arterial disease

Area of Science:

• Vascular Biology
• Biomarkers
• Ischemia Research

Background:

• Peripheral occlusive arterial disease (POAD) involves reduced blood flow, leading to tissue ischemia.
• Endothelial cell dysfunction is a key feature of vascular diseases like POAD.
• Identifying reliable markers of endothelial damage is crucial for assessing disease severity.

Purpose of the Study:

• To investigate the relationship between circulating endothelial cell markers and the ischemic status in patients with POAD.
• To determine if specific markers, such as thrombomodulin and von Willebrand factor, reflect disease severity.

Main Methods:

• Studied 34 patients diagnosed with peripheral occlusive arterial disease.
• Measured plasma levels of thrombomodulin, von Willebrand factor, tissue plasminogen activator, and plasminogen activator inhibitor.
• Assessed ischemic status using transcutaneous oxygen pressure measurements and clinical staging.

Main Results:

• Plasma thrombomodulin levels showed a significant correlation with transcutaneous oxygen pressure (p=0.01) and clinical disease stages (p=0.02).
• Von Willebrand factor levels correlated significantly only with transcutaneous oxygen pressure (p=0.04).
• Tissue plasminogen activator and plasminogen activator inhibitor levels did not show close relationships with ischemic status.

Conclusions:

• Thrombomodulin and von Willebrand factor serve as indicators of endothelial cell damage in POAD.
• The extent of endothelial injury in POAD appears to be directly influenced by the degree of ischemia.
• Thrombomodulin is a particularly strong biomarker for assessing endothelial damage severity in relation to ischemia in POAD.